- Kalir T, Eisberg A, Dottino P, Cohen C. Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe. Gynecol Oncol. 1999 Feb;72(2):208-14. PMID: 10021303 [PubMed – indexed for MEDLINE]
- Kalir T, Rahaman J, Hagopian G, Demopoulos R, Cohen C, Burstein DE. Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas. Arch Pathol Lab Med. 2005 May;129(5):651-4. PMID: 15859637 [PubMed – indexed for MEDLINE]
- Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. Gynecol Oncol. 2000 Aug;78(2):148-51. PMID: 10926794 [PubMed – indexed for MEDLINE]
- Kalir T, Wang BY, Goldfischer M, Haber RS, Reder I, Demopoulos R, Cohen CJ, Burstein DE. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia. Cancer 2002; Feb 15;94(4): 1078-82. PMID: 11920478 [PubMed – indexed for MEDLINE]
- Nezhat FR, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 2002 Jun 1;94 (11): 2935-40. PMID: 12115382 [PubMed – indexed for MEDLINE]
- Kalir T, Rahaman J, Hagopian G, Demopoulos R, Cohen C, Burstein DE. Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas. Arch Pathol Lab Med. 2005 May: 129(5): 651-4. PMID: 15859637 [PubMed – indexed for MEDLINE]
- DeFeo A, Narla G, Hirshfeld J, Camacho-Vanegas O, Narla J, Rose SL, Kalir T, Yao S, Levine A, Birrer MJ, Bonome T, Friedman SL, Buller Re, Martignetti JA. Roles of KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res. 2006 Jun 15; 12(12): 3730-3739. PMID: 16778100 [PubMed – indexed for MEDLINE]
- Kinoshita Y, Kalir T, Rahaman J, Dottino P, Kohtz DS. Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy. Am J Pathol. 2012 Jan; 180(1): 375-89. PMID: 22074739 [PubMed – indexed for MEDLINE]
- Kinoshita Y, Kalir T, Dottino P, Kohtz DS. Nuclear distributions of NUP62 and NUP214 suggest architectural diversity and spatial patterning among nuclear pore complexes. PloS One. 2012; 7(4): e36137 PMID: 22558357 [PubMed – indexed for MEDLINE]
- Parikh A, Lee C, Joseph P, Marchini S, Baccarini A, Kolev V, Romualdi C, Fruscio R, Shah H, Wang F, Mullokandov G, Fishman D, D’Incalci M, Rahaman J, Kalir T, Redline RW, Brown BD, Narla G, DiFeo A. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat Commun. 2014; 5: 2977. PMID: 24394555 [PubMed – indexed for MEDLINE]